Korea's Bridge Biotherapeutics to uncover new druggable sites in oncology, immunology
Korea | News | 0 Comment | 08 Feb, 2022
Bridge Biotherapeutics, a South Korean clinical-stage biotechnology company focused on developing novel drugs for inflam...Read more
Korea to offer inhaled COVID-19 antibody cocktail therapy
Korea | News | 0 Comment | 07 Feb, 2022
Celltrion Group, based in South Korea, has submitted an Investigational New Drug (IND) application to conduct a global P...Read more
Korean firm EuBiologics receives approval for Ph III trial of COVID-19 vaccine
Korea | News | 0 Comment | 04 Feb, 2022
EuBiologics, a South Korean biotech company, has announced that EuCorVac-19, a COVID-19 vaccine candidate obtained appro...Read more
Korea's Samsung Biologics buys full ownership of Samsung Bioepis from Biogen for $2.3B
Korea | News | 0 Comment | 28 Jan, 2022
South Korea-based Samsung Biologics has reached an agreement with Biogen for the buyout of Biogen's stake in the Sa...Read more
Korea proposes ultrasound stimulation as effective therapy for Alzheimer's Disease
Korea | News | 3 Comment | 25 Jan, 2022
A viable treatment strategy for Alzheimer's Disease (AD) involves reducing abnormal protein accumulation in the bra...Read more
Korea uses gold nanoparticles to develop diagnostic platform for COVID-19
Korea | News | 0 Comment | 21 Jan, 2022
Researchers from Chung-Ang University in South Korea have introduced a novel nanotechnology-based platform that can...Read more
Seoul Semiconductor shows myopia improvement using 'SunLike Lighting'
Korea | News | 0 Comment | 17 Jan, 2022
South Korea-based Seoul Semiconductor has confirmed SunLike lighting’s effect on improving myopia, along with...Read more
Korean startup Seegene unveils blueprint for MDx future
Korea | News | 0 Comment | 14 Jan, 2022
Seegene Inc, South Korea-based molecular diagnostics (MDx) startup, has unveiled its blueprint for the future and introd...Read more
South Korea approves Novavax COVID-19 vaccine
Korea | News | 0 Comment | 13 Jan, 2022
US-based Novavax, Inc. and SK bioscience, Co. Limited, a vaccine business subsidiary of Korea-based SK Group, have annou...Read more
Korean firm partners with Sanofi for Parkinson's Disease treatment
Korea | News | 0 Comment | 12 Jan, 2022
ABL Bio, Inc., a South Korea-based clinical-stage biotech developing bispecific antibody technology for immuno-oncology ...Read more
South Korea-based SK Inc. invests $350 M in ‘Centre for Breakthrough Medicines’
Korea | News | 0 Comment | 11 Jan, 2022
The Centre for Breakthrough Medicines (CBM), based in the US, has received $350 million in equity financing from South K...Read more
Korea-based LISCure Biosciences explores treatment for rare liver diseases
Korea | News | 0 Comment | 07 Jan, 2022
LISCure Biosciences Inc., a South Korea-based biotech startup, has executed a research collaboration agreement with US b...Read more
Korean startup Astrogen to use AI for drug design against Parkinson’s Disease
Korea | News | 1 Comment | 06 Jan, 2022
South Korea-based startup Astrogen and Paris-based firm Iktos have announced a research collaboration to use A...Read more
Korean firms to develop new compounds for potential anti-seizure medication
Korea | News | 0 Comment | 05 Jan, 2022
BIORCHESTRA and SK Biopharmaceuticals, based in South Korea, have forged a partnership to research and develop new ...Read more
Korean firm GC Cell to expand availability of Immuncell-LC for liver cancer
Korea | News | 0 Comment | 04 Jan, 2022
South Korea-based GC Cell and Indian firm Rivaara Immune have entered into an exclusive licensing agreement, pursuant to...Read more
Korea introduces low-cost artificial cochlear implant 'Sullivan'
Korea | News | 0 Comment | 03 Jan, 2022
South Korea-based startup TODOC has developed an artificial cochlear implant 'SULLIVAN'. Based on the vision of co...Read more
Korea's iMedisync develops world's first integrated wireless brain EEG
Korea | News | 0 Comment | 01 Jan, 2022
iMediSync, a leading AI-driven early detection and therapeutic platform for optimal brain health from Seoul, South ...Read more
Korean startup ImmuneOncia enhances biologics portfolio for cancer patients
Korea | News | 0 Comment | 28 Dec, 2021
ImmuneOncia Therapeutics, Inc., a clinical-stage, immuno-oncology startup in South Korea, has announced that a Memorandu...Read more